Greater CD8+ TCR heterogeneity and functional flexibility in HIV-2 compared to HIV-1 infection.
about
Integrating in silico and in vitro analysis of peptide binding affinity to HLA-Cw*0102: a bioinformatic approach to the prediction of new epitopesLongitudinal assessment of human immunodeficiency virus type 1 (HIV-1)-specific gamma interferon responses during the first year of life in HIV-1-infected infants.Protection versus pathology in aviremic and high viral load HIV-2 infection-the pivotal role of immune activation and T-cell kinetics.Comparing HIV-1 and HIV-2 infection: Lessons for viral immunopathogenesis.Not all cytokine-producing CD8+ T cells suppress simian immunodeficiency virus replicationHLA B*5701-positive long-term nonprogressors/elite controllers are not distinguished from progressors by the clonal composition of HIV-specific CD8+ T cells.Comparison of heterologous neutralizing antibody responses of human immunodeficiency virus type 1 (HIV-1)- and HIV-2-infected Senegalese patients: distinct patterns of breadth and magnitude distinguish HIV-1 and HIV-2 infectionsRobust Gag-specific T cell responses characterize viremia control in HIV-2 infection.The efficiency of Vpx-mediated SAMHD1 antagonism does not correlate with the potency of viral control in HIV-2-infected individuals.Out of Africa: what can we learn from HIV-2 about protective immunity to HIV-1?Higher homologous and lower cross-reactive Gag-specific T-cell responses in human immunodeficiency virus type 2 (HIV-2) than in HIV-1 infectionGag-specific CD4+ T-cell frequency is inversely correlated with proviral load and directly correlated with immune activation in infection with human immunodeficiency virus type 2 (HIV-2) but not HIV-1.Comparison of viro-immunological marker changes between HIV-1 and HIV-2-infected patients in France.Comparison of human immunodeficiency virus (HIV)-specific T-cell responses in HIV-1- and HIV-2-infected individuals in Senegal.Preservation of Lymphopoietic Potential and Virus Suppressive Capacity by CD8+ T Cells in HIV-2-Infected Controllers.Fluctuations of functionally distinct CD8+ T-cell clonotypes demonstrate flexibility of the HIV-specific TCR repertoire.Clonal focusing of epitope-specific CD8+ T lymphocytes in rhesus monkeys following vaccination and simian-human immunodeficiency virus challenge.Comprehensive analysis of HIV Gag-specific IFN-gamma response in HIV-1- and HIV-2-infected asymptomatic patients from a clinical cohort in The Gambia.Towards the chemometric dissection of peptide--HLA-A*0201 binding affinity: comparison of local and global QSAR models.Highly avid, oligoclonal, early-differentiated antigen-specific CD8+ T cells in chronic HIV-2 infection
P2860
Q33517118-91BBAC44-4A89-4CEF-9F24-6D4B73918939Q33843438-7B099096-3EDA-4501-BC68-5932EDD47AF6Q34034072-BEBA453B-E760-4DDF-AE8F-FF55C3B8D063Q34035802-B73962F6-8C66-4B02-A0D1-4AF391918D8AQ35635247-16C2336F-E412-43CA-9B49-5241DBB0D96BQ35826897-28C5912B-D0A1-4445-A26B-0901FB56B1E1Q35857480-739CB7EC-7608-465D-934E-2FDFBB07005AQ35970916-96AEBAEF-3F94-4D10-8D73-A28F008C597CQ36690419-0B9B37F5-30C7-450E-8263-841054F15C7FQ36765448-AE3C9B6C-8918-4971-888B-6B5B7A637937Q36845911-EC5A4218-ED73-4647-84B7-A81FE3ADB8D1Q36898820-04C518CD-1770-4ADE-9093-95A19471A701Q37307096-25F68B62-911A-4EE2-883A-2D72F513358FQ37682830-EFFDAE70-5529-400C-895A-B0D20F5AE790Q39448439-A78403D1-B501-42C6-8B2D-D5AD48198EE5Q41880425-7DF759C5-113A-4F4B-BE6B-0A601D9896B3Q41914685-EBC9155C-779A-4B3F-8056-1BF8C75DAA2CQ44457386-CFF96132-97D9-487D-8557-C02F2BC6C0C3Q51967888-05CBDB4D-DBBF-4E6F-87D8-6517D1FB41CBQ56787219-3BF00AC3-5D06-49D2-8E58-E5FFFC052F35
P2860
Greater CD8+ TCR heterogeneity and functional flexibility in HIV-2 compared to HIV-1 infection.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
Greater CD8+ TCR heterogeneity ...... 2 compared to HIV-1 infection.
@en
Greater CD8+ TCR heterogeneity ...... 2 compared to HIV-1 infection.
@nl
type
label
Greater CD8+ TCR heterogeneity ...... 2 compared to HIV-1 infection.
@en
Greater CD8+ TCR heterogeneity ...... 2 compared to HIV-1 infection.
@nl
prefLabel
Greater CD8+ TCR heterogeneity ...... 2 compared to HIV-1 infection.
@en
Greater CD8+ TCR heterogeneity ...... 2 compared to HIV-1 infection.
@nl
P2093
P50
P1476
Greater CD8+ TCR heterogeneity ...... 2 compared to HIV-1 infection.
@en
P2093
A Ross Lopes
Abraham Alabi
Assan Jaye
Darren R Flower
Hilton Whittle
Ian Williams
Lucy Dorrell
Nicola A Jones
Phillipa Newton
R Monica Lascar
P304
P356
10.4049/JIMMUNOL.171.1.307
P407
P577
2003-07-01T00:00:00Z